{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T02:30:20Z","timestamp":1761964220544},"reference-count":22,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Genetics and Cytogenetics"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1016\/j.cancergencyto.2009.02.012","type":"journal-article","created":{"date-parts":[[2009,5,28]],"date-time":"2009-05-28T08:49:34Z","timestamp":1243500574000},"page":"36-39","source":"Crossref","is-referenced-by-count":22,"title":["Insertion (12;9)(p13;q34q34): a cryptic rearrangement involving ABL1\/ETV6 fusion in a patient with Philadelphia-negative chronic myeloid leukemia"],"prefix":"10.1016","volume":"192","author":[{"given":"JoAnn C.","family":"Kelly","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nasrin","family":"Shahbazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jay","family":"Scheerle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Jahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephany","family":"Suchen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole C.","family":"Christacos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip N.","family":"Mowrey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary H.","family":"Witt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alden","family":"Hostetter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aurelia M.","family":"Meloni-Ehrig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cancergencyto.2009.02.012_bib1","first-page":"169","article-title":"Chronic myelogenous leukemia: update on biology and treatment","volume":"13","author":"Faderl","year":"1999","journal-title":"Oncology (Williston Park)"},{"key":"10.1016\/j.cancergencyto.2009.02.012_bib2","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1182\/blood.V96.10.3343","article-title":"The molecular biology of chronic myeloid leukemia","volume":"96","author":"Deininger","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2009.02.012_bib3","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1159\/000046636","article-title":"Cytogenetic and molecular genetic evolution of chronic myeloid leukemia","volume":"107","author":"Johansson","year":"2002","journal-title":"Acta Haematol"},{"key":"10.1016\/j.cancergencyto.2009.02.012_bib4","first-page":"34","article-title":"The novel activation of ABL by fusion to an ETS-related gene, TEL","volume":"55","author":"Papadopoulos","year":"1995","journal-title":"Cancer Res"},{"key":"10.1016\/j.cancergencyto.2009.02.012_bib5","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1002\/gcc.20593","article-title":"Chronic phase of ETV6-ABL1 positive CML responds to imatinib","volume":"47","author":"Kawamata","year":"2008","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergencyto.2009.02.012_bib6","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/(SICI)1098-2264(199711)20:3<299::AID-GCC11>3.0.CO;2-K","article-title":"BRC\/ABL-negative chronic myeloid leukemia with ETV6\/ABL fusion","volume":"20","author":"Andreasson","year":"1997","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergencyto.2009.02.012_bib7","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.1128\/MCB.16.8.4107","article-title":"Oligomerization of the ABL tyrosine kinase by the Ets protein TEL in human leukemia","volume":"16","author":"Golub","year":"1996","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.cancergencyto.2009.02.012_bib8","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/1098-2264(2000)9999:9999<1::AID-GCC1089>3.0.CO;2-1","article-title":"Molecular cytogenetic and clinical findings in ETV6\/ABL1-positive leukemia","volume":"30","author":"Van Limbergen","year":"2001","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergencyto.2009.02.012_bib9","first-page":"789","article-title":"Clonal eosinophils are a morphologic hallmark of ETV6\/ABL1 positive acute myeloid leukemia","volume":"87","author":"La Starza","year":"2002","journal-title":"Haematologica"},{"key":"10.1016\/j.cancergencyto.2009.02.012_bib10","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/sj.leu.2402353","article-title":"Detection of dual TEL-ABL transcripts and a TEL-ABL protein containing phosphotyrosine in a chronic myeloid leukemia patient","volume":"16","author":"Lin","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2009.02.012_bib11","doi-asserted-by":"crossref","first-page":"3465","DOI":"10.1182\/blood.V99.9.3465","article-title":"Transient response to imatinib mesylate (STI571) in a patient with the ETV6-ABL t(9;12) translocation","volume":"99","author":"O'Brien","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2009.02.012_bib12","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1046\/j.1365-2141.2003.04391.x","article-title":"Clinical and genetic studies of ETV6\/ABL 1-positive chronic myeloid leukaemia in blast crisis treated with imatinib mesylate","volume":"122","author":"Barbouti","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cancergencyto.2009.02.012_bib13","doi-asserted-by":"crossref","first-page":"4374","DOI":"10.1093\/emboj\/16.14.4374","article-title":"Yolk sac angiogenic defect and intra-embryonic apoptosis in mice lacking the ETS-related factor TEL","volume":"16","author":"Wang","year":"1997","journal-title":"EMBO J"},{"key":"10.1016\/j.cancergencyto.2009.02.012_bib14","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1101\/gad.12.15.2392","article-title":"The TEL\/ETV6 gene is required specifically for hematopoiesis in the bone marrow","volume":"12","author":"Wang","year":"1998","journal-title":"Genes Dev"},{"key":"10.1016\/j.cancergencyto.2009.02.012_bib15","unstructured":"Mitelman F, Johansson B, Mertens F, editors. Mitelman database of chromosome aberrations in cancer [Internet]. Updated Aug. 2008. Accessed Aug. 31, 2008. Available athttp:\/\/cgap.nci.nih.gov\/Chromosomes\/Mitelman."},{"key":"10.1016\/j.cancergencyto.2009.02.012_bib16","series-title":"ISCN 2005: an international system for human cytogenetic nomenclature","year":"2005"},{"key":"10.1016\/j.cancergencyto.2009.02.012_bib17","first-page":"147","article-title":"Prognostic implications of breakpoint and lineage heterogeneity in Philadelphia-positive acute lymphoblastic leukemia: a review","volume":"7","author":"Secker-Walker","year":"1993","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2009.02.012_bib18","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00062752-199704010-00002","article-title":"The function of BCR\/ABL and related proto-oncogenes","volume":"4","author":"Gotoh","year":"1997","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.cancergencyto.2009.02.012_bib19","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1182\/blood.V96.6.2269","article-title":"Bcr\/Abl activates transcription of the Bcl-X gene through STAT5","volume":"96","author":"Gesbert","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2009.02.012_bib20","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1046\/j.1365-2141.1998.00803.x","article-title":"Haemopoietic transformation by the TEL\/ABL oncogene","volume":"102","author":"Hannemann","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cancergencyto.2009.02.012_bib21","doi-asserted-by":"crossref","first-page":"4568","DOI":"10.1182\/blood-2001-12-0244","article-title":"The TEL-ABL (ETV6-ABL) tyrosine kinase product of complex (9;12) translocations in human leukemia induces distinct myeloproliferative disease in mice","volume":"99","author":"Million","year":"2002","journal-title":"Blood"},{"issue":"4 Suppl","key":"10.1016\/j.cancergencyto.2009.02.012_bib22","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/S1471-4914(02)02305-5","article-title":"STI571 (Gleevec) as a paradigm for cancer therapy","volume":"8","author":"Druker","year":"2002","journal-title":"Trends Mol Med"}],"container-title":["Cancer Genetics and Cytogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016546080900106X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016546080900106X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T20:49:50Z","timestamp":1589834990000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016546080900106X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["S016546080900106X"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergencyto.2009.02.012","relation":{},"ISSN":["0165-4608"],"issn-type":[{"value":"0165-4608","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}